Navigating third-line therapies: A comprehensive review of regorafenib versus fruquintinib with placebo comparator for metastatic colorectal cancer—A systematic review and meta-analysis.

Authors: Aria Khan, Imran Khan, Shahzaib Maqbool, Arham Ihtesham, Adil Khan, Pouyan Gohari

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e15514

Source: Full article

e15514